An Analysis of Approaches to the Management of Endometrial Cancer in North America: A CTF Study

• Published in: Gynecologic oncology 1998-03, Vol.68 (3), p.274-279
• Main Authors: Maggino, Tiziano, Romagnolo, Cesare, Landoni, Fabio, Sartori, Enrico, Zola, Paolo, Gadducci, Angiolo
• Format: Article
• Language: English
• Subjects: adjuvant treatment; Adult; Age Factors; Aged; Biological and medical sciences; Combined Modality Therapy; endometrial cancer; Endometrial Neoplasms - pathology; Endometrial Neoplasms - therapy; Female; Female genital diseases; Gynecology. Andrology. Obstetrics; Humans; Hysterectomy; Lymph Node Excision; Medical sciences; Menopause; Middle Aged; Neoplasm Staging; North America; Radiotherapy, Adjuvant; staging; surgical therapy; Tumors
• ISSN: 0090-8258; 1095-6859
• DOI: 10.1006/gyno.1998.4951

Objective.The aim of this study was to define the clinical–therapeutical approach to endometrial cancer now being followed in some of the most important centers of reference for gynecological cancer in North America by means of a questionnaire. Study design.The questionnaire focused on four principal areas: (1) surgical staging and therapy; (2) adjuvant treatment; (3) treatment modifications; and (4) management of advanced stages (FIGO III–IV). Results.There were 48 evaluable responses (77%) received by the end of December 1994 which were considered for this analysis. Lymphadenectomy is utilized routinely in 26/48 centers (54.2%) and in selective clinical–pathological conditions in another 21/48 centers (43.5%). In the majority of centers (31/48; 64.6%) radical surgery is utilized for selected indications such as cervical involvement. Only 3/48 (6.2%) centers consider the vaginal approach totally inappropriate. The great majority (40/48; 83.3%) of the centers considered postsurgical adjuvant therapy to be necessary in FIGO Stage Ic. Brachytherapy is routinely performed in 3 centers (6.2%) in postsurgical management of Stage I endometrial cancer, while the majority of the centers (31/48; 64.6%) perform brachytherapy of the vaginal vault in certain clinical–pathological conditions. A wide variety of treatments are used for advanced stages (FIGO III–IV). Conclusions.It emerges that some controversial aspects exist on endometrial cancer treatment, and these conflicting data need a large-scale multicenter randomized clinical trial.